C. Schulz Et Al. , "First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN): Impact of brain metastases on treatment patterns and outcomes," ONCOLOGY RESEARCH AND TREATMENT , vol.43, pp.144-145, 2020
Schulz, C. Et Al. 2020. First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN): Impact of brain metastases on treatment patterns and outcomes. ONCOLOGY RESEARCH AND TREATMENT , vol.43 , 144-145.
Schulz, C., Chen, Y., Paz-Ares, L. G., Dvorkin, M., Trukhin, D., Reinmuth, N., ... Garassino, M. C.(2020). First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN): Impact of brain metastases on treatment patterns and outcomes. ONCOLOGY RESEARCH AND TREATMENT , vol.43, 144-145.
Schulz, C. Et Al. "First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN): Impact of brain metastases on treatment patterns and outcomes," ONCOLOGY RESEARCH AND TREATMENT , vol.43, 144-145, 2020
Schulz, C. Et Al. "First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN): Impact of brain metastases on treatment patterns and outcomes." ONCOLOGY RESEARCH AND TREATMENT , vol.43, pp.144-145, 2020
Schulz, C. Et Al. (2020) . "First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN): Impact of brain metastases on treatment patterns and outcomes." ONCOLOGY RESEARCH AND TREATMENT , vol.43, pp.144-145.
@article{article, author={C. Schulz Et Al. }, title={First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN): Impact of brain metastases on treatment patterns and outcomes}, journal={ONCOLOGY RESEARCH AND TREATMENT}, year=2020, pages={144-145} }